Prosecution Insights
Last updated: August 18, 2026

Examiner: LEESER, ERICH A

Tech Center 1600 • Art Units: 1622 1624

This examiner grants 82% of resolved cases

Performance Statistics

81.6%
Allow Rate
+21.6% vs TC avg
980
Total Applications
+13.5%
Interview Lift
763
Avg Prosecution Days
Based on 958 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
23.7%
§102 Novelty
14.7%
§103 Obviousness
39.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19426142 PRMT5 INHIBITORS AND METHODS OF USE Non-Final OA SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED
18543130 COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND TITANIUM DIOXIDE Non-Final OA L'OREAL
18562100 TREATMENT OF INFECTIONS IN AND AROUND THE EYE Non-Final OA UNIVERSITY OF MIAMI

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month